Drug intelligence / Profile preview

docusate + benzocaine

Development stage
Unknown
Lead developer
Beijing Beiliyuan Pharmaceutical Technology
Modality
Small Molecules
Administration
Rectal
01

Overview

Docusate + benzocaine is a combination pharmacological agent used for the treatment of chronic constipation and bowel management, particularly in patients with spinal cord injuries or neurological disorders. Docusate sodium functions as an anionic surfactant and stool softener; it reduces the surface tension of the fecal mass, allowing water and lipids to penetrate and soften the stool, thereby facilitating easier evacuation. Benzocaine is a local anesthetic of the ester type that acts by inhibiting voltage-gated sodium channels on the neuronal membrane, providing a rapid numbing effect to the rectal mucosa. This combination not only eases the passage of stool but also minimizes the discomfort and pain associated with defecation. Beijing Beiliyuan Pharmaceutical Technology Co., Ltd. is a known developer of this combination, typically formulated as a rectal solution or mini-enema for rapid onset of action.

Brand names
Enemeez PlusDocu-Sol PlusTherevac-Plus
Other names
docusate sodium and benzocainebenzocaine and docusate sodium
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on docusate + benzocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on docusate + benzocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call